1. Home
  2. ALKS vs ACA Comparison

ALKS vs ACA Comparison

Compare ALKS & ACA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • ACA
  • Stock Information
  • Founded
  • ALKS 1987
  • ACA 2018
  • Country
  • ALKS Ireland
  • ACA United States
  • Employees
  • ALKS N/A
  • ACA N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • ACA Metal Fabrications
  • Sector
  • ALKS Health Care
  • ACA Industrials
  • Exchange
  • ALKS Nasdaq
  • ACA Nasdaq
  • Market Cap
  • ALKS 4.9B
  • ACA 4.2B
  • IPO Year
  • ALKS 1991
  • ACA N/A
  • Fundamental
  • Price
  • ALKS $30.82
  • ACA $90.38
  • Analyst Decision
  • ALKS Strong Buy
  • ACA Strong Buy
  • Analyst Count
  • ALKS 14
  • ACA 3
  • Target Price
  • ALKS $41.43
  • ACA $112.00
  • AVG Volume (30 Days)
  • ALKS 1.9M
  • ACA 210.0K
  • Earning Date
  • ALKS 10-23-2025
  • ACA 10-29-2025
  • Dividend Yield
  • ALKS N/A
  • ACA 0.22%
  • EPS Growth
  • ALKS 21.99
  • ACA N/A
  • EPS
  • ALKS 2.08
  • ACA 1.87
  • Revenue
  • ALKS $1,505,296,000.00
  • ACA $2,675,500,000.00
  • Revenue This Year
  • ALKS N/A
  • ACA $12.92
  • Revenue Next Year
  • ALKS $1.59
  • ACA $6.55
  • P/E Ratio
  • ALKS $14.89
  • ACA $48.31
  • Revenue Growth
  • ALKS N/A
  • ACA 9.78
  • 52 Week Low
  • ALKS $25.17
  • ACA $68.11
  • 52 Week High
  • ALKS $36.45
  • ACA $113.43
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 62.83
  • ACA 38.45
  • Support Level
  • ALKS $26.99
  • ACA $91.70
  • Resistance Level
  • ALKS $31.68
  • ACA $93.72
  • Average True Range (ATR)
  • ALKS 0.80
  • ACA 2.08
  • MACD
  • ALKS 0.36
  • ACA -0.52
  • Stochastic Oscillator
  • ALKS 81.88
  • ACA 0.14

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About ACA Arcosa Inc.

Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.

Share on Social Networks: